May 17, 2021 — In patients who received a coronary stent for an ST-elevation myocardial infarction (STEMI) heart attack, the use of fractional flow reserve (FFR) to see if a second stent is needed did not improve outcomes and was more costly than using angiography. The study found guiding procedures with angiography X-ray imaging alone and more effective. 

DAIC magazine won Overall Excellence Finalist/Multi-platform Package of the Year for its coverage of the COVID-19 Pandemic’s Toll on Cardiology, National. The entry won an honor mention for its coverage of the COVID pandemic. Dave Fornell is the editor of DAIC.
Overall Excellence Finalist/Multi-platform Package of the Year for its coverage of the Pandemic’s Toll on Cardiology, National
Online Video/News for its Enterprising Medical Video Tour During the COVID Era, Regional Silver

Diagnostic and Interventional Cardiology (DAIC) and its sister publication Imaging Technology News (ITN) recently took home honors from the American Society of Business Publication Editors (ASBPE) 2021

The Record Paradise RDN catheter uses a balloon catheter filled with water to cool the vessel wall as ultrasound-based ablation energy is delivered. It delivers a ring of ablative energy to a depth of 1-6 mm. Kirtane said it requires 2-3 sonications lasting 7 seconds each in each of the main renal arteries. #ACC21 #ACC2021 #RDN

May 16, 2021 — Two months after undergoing renal denervation (RDN) with the ReCor Paradise renal denervation system, patients with high blood pressure who did not respond to treatment with multiple medications had a greater reduction in daytime systolic blood pressure than patients who did not receive RDN, with no difference in major adverse effects.
Etripamil nasal spray was shown in a post-hoc analysis to resolve paroxysmal supraventricular tachycardia faster and more completely than placebo in most patients and reduced the number of emergency room visits for additional interventions. 

May 16, 2020 — New data from in the NODE-301 Trial for the patient-administered nasal spray etripamil to resolve paroxysmal supraventricular tachycardia (PSVT) found the drug helps reduce emergency room visits and significantly reduced symptoms as compared to placebo. This was the finding of a new post-trial data analysis presented at the American College of Cardiology (ACC) 2021 virtual scientific session. 
The Boston Scientific Watchman device have performed better than expected in real-world patients outside of trials since it was introduced in 2015, according to data from the NCDR LAAO Registry. #ACC21 #ACC2021 #LAA #Watchman

May 15, 2021 - Transcatheter left atrial appendage occlusion (LAAO) with a Boston Scientific Watchman device was associated with a low rate of stroke at one year even among older patients with atrial fibrillation (AFib) who faced a high risk for stroke or bleeding according to new data presented at the American College of Cardiology (ACC) 2021 scientific session. 

May 15, 2021 — A new analysis of the Phase 3 EXPLORER-HCM study evaluating mavacamten, an investigational, first-in-class cardiac myosin inhibitor, in patients with obstructive hypertrophic cardiomyopathy (oHCM), found at 30 weeks improvement in the Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ OSS) was greater in mavacamten patients than placebo.

May 15, 2021 — The combination heart failure drug sacubitril/valsartan (Entresto) did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin converting enzyme (ACE) inhibitor proven effective in improving survival following heart attacks.

May 15, 2021 — Patients with an elevated risk of stroke due to heart rhythm problems, or atrial fibrillation (AFib), were much less likely to suffer a stroke after undergoing heart surgery if doctors concurrently performed an additional left atrial appendage occlusion (LAAO) procedure, according to the results of the LAAOS III late-breaking trial presented at the

May 15, 2021 — The ADAPTABLE trial found no significant differences in cardiovascular events or major bleeding in patients with pre-existing cardiovascular disease who were taking 81 milligrams (mg) baby aspirin, versus 325 mg of daily aspirin, according to new data presented at the American College of Cardiology (ACC) 2021 virtual scientific session. This study simultaneously published online in the New England Journal of Medicine.[1]

May 15, 2021 — The anticoagulant apixaban (Eliquis) was not superior to standard of care following transcatheter aortic valve replacement (TAVR), according to findings from a new trial called ATLANTIS presented at the American College of Cardiology (ACC) 2021 virtual scientific session.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now